Clarity Pharmaceuticals has piqued my interest lately. Recently I was diagnosed with prostate cancer and I am a potential beneficiary of this new technology, if the trials are successful and the imaging is approved.

PSMA PET/CT is currently the most accurate imaging test for detecting prostate cancer in men. It has been a game changer as it can detect very small prostate antigen specific cancers that may be missed by other scans and it can more accurately stage cancers.

Clarity Pharmaceutical’s 64Cu SAR-bisPSMA promises another level up in accuracy. In my case the cancer is confined to the prostate… for now! This new technology has the potential to pick up metastatic spread of prostate cancer more accurately and before it becomes a problem.

According to a note shared by James Mickleboro from The Motley Fool, Bell Potter is bullish on the prospects for Clarity in 2025, particularly given the impending release of the final data from the SECuRE trial.

“SECuRE is a Phase I/IIa theranostic trial for identification and treatment of participants with prostate-specific membrane antigen (PSMA)-expressing metastatic castrate-resistant prostate cancer.

Commenting on the company, the broker said:

Clarity Pharmaceuticals has continued to produce high quality interim data readouts from its numerous clinical trials during 2024. In 2025 we anticipate a flood of new data led by headline readouts from the pivotal study in prostate cancer imaging (CLARIFY) and perhaps more importantly, final data from SECuRE being the therapy trial also in prostate cancer.

Earlier data from imaging studies indicates 64Cu SAR-bisPSMA is able to detect cancerous lesions in lymph nodes at a far earlier stage than the standard of care. Similarly, PSA50 data from the SECuRE trial is highly anticipated and is expected to be highly supportive of further development of this drug candidate.

Bell Potter currently has a speculative buy rating and $10.00 price target on its shares.”

Don’t be complacent!

I’d like to take this opportunity to remind all my Strawman mates out there who are over the age of 50 to make sure you have a PSA blood test every year. If you are over 50 and haven’t been tested yet, don’t delay! Make an appointment with your GP today, get a blood test, then rinse and repeat annually. It’s important to establish a trend in PSA results.

I’ve had yearly PSA blood tests for over a decade now. I had no symptoms of prostrate cancer and the rising PSA levels were the only alert I had. This led to follow up testing. An annual PSA blood test can save your life. Don’t be complacent. See the stats below.

I’ve got plenty of mates out there to share my issues with…more than I realised! If you’re one of us and you are struggling to deal with it, or just want to chat about it, feel free to DM me. There is lots of great support out there!

Worldwide, prostate cancer is the second most commonly diagnosed cancer and the fifth leading cause of cancer death among men, with an estimated 1,414,000 new cancer cases and 375,304 deaths in 2020. https://www.prostate.org.au/risk-and-symptoms/facts-figures/#:~:text=Prostate%20cancer%20is%20the%20most,of%20all%20newly%20diagnosed%20cancers.

“Nearly 72 Australian men are diagnosed every day, with 1 in 5 at risk of being diagnosed in their lifetime, according to the estimates. This is because your risk of prostate cancer increases as you get older.

Of the Australian men predicted to be diagnosed with prostate cancer in 2024:

• 416 (1.8%) will be under 49
• 3,233 (12.3%) will be 50–59
• 9,559 (36.3%) will be 60–69
• 9,584 (36.3%) will be 70–79
• 3,572 (13.6%) will be over 80

Disc: Not held, but on my watch list